BioSpace News Archive

The opposition to Takeda Pharmaceutical acquiring Shire has taken on another dimension with a prominent member of the family that created the Japanese pharmaceutical company speaking publicly against the deal.

As the weather cools down, let’s look back at this summer’s most popular career advice on BioSpace.

Cellmid Limited today advised that the Share Purchase Plan (“SPP”) announced on 31 July 2018 with an offer price of $0.38 has now closed.

Dream-Kicker.com to offer donation-based, cryptocurrency support for cutting-edge regenerative medicine and medical equipment

A randomized, placebo and gold-standard controlled clinical trial, investigating the treatment of incipient buccal caries lesions with CURODONT™ REPAIR was presented at the IADR 2018 in London. In this study Prof. Krejci and his team at the University of Geneva showed that the use of CURODONT™ REPAIR is superior to that of fluoride varnish or a placebo treatment.

Cooperative effort will ensure top quality plants for medical treatment

Biom’up today announces Dr. Peter Byloos’ co-optation to its Board of Directors as an independent director.

Today the Society for Clinical Research Sites (SCRS) announced the finalists for the 2018 SCRS Eagle Award™, selected from companies nominated by SCRS members.

All evaluable patients experienced tumor shrinkage

Polyphor AG today announced its financial results for the first half of 2018.